UT MD Anderson Cancer Center
Anton Liopo earned his PhD degree from the Institute of Physiology the National Academy of Science of Belarus (NASB). He later went on to join the Institute of Biochemistry of NASB, where he successfully worked to climb the ladder from a young scientist to a seasoned Senior Scientist, Associate Professor, and eventually the Director of Government Program. After moving to the United States, Dr. Liopo obtained trainings in molecular biology in Department Internal Medicine and nanotechnology in Center for Biomedical Engineering (CBE) at the University of Texas, Medical Branch (UTMB) at Galveston. Dr. Liopo was the leading researcher in nanoparticle-cell interaction at the CBE at UTMB. After successful work within academic research groups, he was invited to join TomoWave Laboratories Inc. (Houston, TX) where he was lead Scientist supervising the nanobiotechnology program and investigations of novel nanoparticles to develop molecular probe for improving molecular sensing, and contrast diagnostics and therapy. Now Dr. Liopo continues his investigations in Center for Radiation Oncology Research, UT MD Anderson Cancer Center, where he is aiming on novel nanocomposites for enhancement of cancer radio-therapy. As Principal Scientist in Pinami LLC, Houston TX, he is focusing on study of light and sound propagation in different tissue. Dr. Liopo is also a visiting scientist in Department of Chemistry of Rice University, where he is responsible for study of nanocomposites for biomedical applications and trainings of post graduate students. Dr. Liopo has served for International Scientific Conference Committees in the USA, China, UAE and other countries. He is a regular reviewer and member of several editorial boards of scientific journals. Dr. Liopo has more than 75 peer-reviewed publications, including monograph, book chapters and patents.